Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A tularemia that results in bacteremia and has symptom fever, has symptom chills, has symptom myalgia, has symptom malaise, and has symptom weight loss.
Biomarker and diagnostic research for typhoidal tularemia has been reported in the published literature.
No clinical trials have been registered for typhoidal tularemia.
6 publications have been identified in PubMed for typhoidal tularemia. Research spans Case Report / Case Series (33%), Epidemiology / Natural History (33%), and Diagnostic / Biomarker (17%).
Gaber DT (2026). [PMID: 41612584](https://pubmed.ncbi.nlm.nih.gov/41612584/). *Emerging infectious diseases*. [Epidemiology / Natural History]
Watson JR (2025). [PMID: 41160772](https://pubmed.ncbi.nlm.nih.gov/41160772/). *The Permanente journal*. [Diagnostic / Biomarker]
Othman L (2025). [PMID: 40791139](https://pubmed.ncbi.nlm.nih.gov/40791139/). *Lakartidningen*. [Epidemiology / Natural History]
Antonello RM (2025). [PMID: 40107886](https://pubmed.ncbi.nlm.nih.gov/40107886/). *European journal of internal medicine*. [Review / Meta-Analysis]
Nelson BD (2025). [PMID: 41385785](https://pubmed.ncbi.nlm.nih.gov/41385785/). *Emerging infectious diseases*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 5:34 AM UTC
AI-curated news mentioning typhoidal tularemia
Updated Aug 1, 2026
A recent study highlights pediatric tularemia as a neglected disease in Denmark, emphasizing the need for increased awareness and research. The findings suggest that this infectious disease, caused by the bacterium Francisella tularensis, may be underdiagnosed in children.
A case study highlights a patient with pulmonary tularemia experiencing a relapse of tularemia orchitis while on a TNF-alpha inhibitor. This finding underscores the potential risks associated with immunosuppressive therapies in rare infectious diseases.
A recent study published in PubMed details the histopathologic findings associated with tularemia lymphadenitis. This research enhances understanding of the disease's pathology, which may inform future diagnostic and therapeutic strategies.